These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 27721502)

  • 1. Calcium dysregulation contributes to neurodegeneration in FTLD patient iPSC-derived neurons.
    Imamura K; Sahara N; Kanaan NM; Tsukita K; Kondo T; Kutoku Y; Ohsawa Y; Sunada Y; Kawakami K; Hotta A; Yawata S; Watanabe D; Hasegawa M; Trojanowski JQ; Lee VM; Suhara T; Higuchi M; Inoue H
    Sci Rep; 2016 Oct; 6():34904. PubMed ID: 27721502
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Integrative system biology analyses of CRISPR-edited iPSC-derived neurons and human brains reveal deficiencies of presynaptic signaling in FTLD and PSP.
    Jiang S; Wen N; Li Z; Dube U; Del Aguila J; Budde J; Martinez R; Hsu S; Fernandez MV; Cairns NJ; ; ; Harari O; Cruchaga C; Karch CM
    Transl Psychiatry; 2018 Dec; 8(1):265. PubMed ID: 30546007
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Defective proteostasis in induced pluripotent stem cell models of frontotemporal lobar degeneration.
    Mahali S; Martinez R; King M; Verbeck A; Harari O; Benitez BA; Horie K; Sato C; Temple S; Karch CM
    Transl Psychiatry; 2022 Dec; 12(1):508. PubMed ID: 36494352
    [TBL] [Abstract][Full Text] [Related]  

  • 4. iPSC-induced neurons with the V337M MAPT mutation are selectively vulnerable to caspase-mediated cleavage of tau and apoptotic cell death.
    Theofilas P; Wang C; Butler D; Morales DO; Petersen C; Ambrose A; Chin B; Yang T; Khan S; Ng R; Kayed R; Karch CM; Miller BL; Gestwicki JE; Gan L; Temple S; Arkin MR; Grinberg LT
    Mol Cell Neurosci; 2024 Sep; 130():103954. PubMed ID: 39032719
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Continuous Monitoring of Tau-Induced Neurotoxicity in Patient-Derived iPSC-Neurons.
    Oakley DH; Klickstein N; Commins C; Chung M; Dujardin S; Bennett RE; Hyman BT; Frosch MP
    J Neurosci; 2021 May; 41(19):4335-4348. PubMed ID: 33893219
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mitotic defects lead to neuronal aneuploidy and apoptosis in frontotemporal lobar degeneration caused by MAPT mutations.
    Caneus J; Granic A; Rademakers R; Dickson DW; Coughlan CM; Chial HJ; Potter H
    Mol Biol Cell; 2018 Mar; 29(5):575-586. PubMed ID: 29282277
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tau inhibits mitochondrial calcium efflux and makes neurons vulnerable to calcium-induced cell death.
    Britti E; Ros J; Esteras N; Abramov AY
    Cell Calcium; 2020 Mar; 86():102150. PubMed ID: 31918031
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MAPT genotype-dependent mitochondrial aberration and ROS production trigger dysfunction and death in cortical neurons of patients with hereditary FTLD.
    Korn L; Speicher AM; Schroeter CB; Gola L; Kaehne T; Engler A; Disse P; Fernández-Orth J; Csatári J; Naumann M; Seebohm G; Meuth SG; Schöler HR; Wiendl H; Kovac S; Pawlowski M
    Redox Biol; 2023 Feb; 59():102597. PubMed ID: 36599286
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Comprehensive Resource for Induced Pluripotent Stem Cells from Patients with Primary Tauopathies.
    Karch CM; Kao AW; Karydas A; Onanuga K; Martinez R; Argouarch A; Wang C; Huang C; Sohn PD; Bowles KR; Spina S; Silva MC; Marsh JA; Hsu S; Pugh DA; Ghoshal N; Norton J; Huang Y; Lee SE; Seeley WW; Theofilas P; Grinberg LT; Moreno F; McIlroy K; Boeve BF; Cairns NJ; Crary JF; Haggarty SJ; Ichida JK; Kosik KS; Miller BL; Gan L; Goate AM; Temple S;
    Stem Cell Reports; 2019 Nov; 13(5):939-955. PubMed ID: 31631020
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetically engineered MAPT 10+16 mutation causes pathophysiological excitability of human iPSC-derived neurons related to 4R tau-induced dementia.
    Kopach O; Esteras N; Wray S; Abramov AY; Rusakov DA
    Cell Death Dis; 2021 Jul; 12(8):716. PubMed ID: 34274950
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Generation of a human induced pluripotent stem cell-based model for tauopathies combining three microtubule-associated protein TAU mutations which displays several phenotypes linked to neurodegeneration.
    García-León JA; Cabrera-Socorro A; Eggermont K; Swijsen A; Terryn J; Fazal R; Nami F; Ordovás L; Quiles A; Lluis F; Serneels L; Wierda K; Sierksma A; Kreir M; Pestana F; Van Damme P; De Strooper B; Thorrez L; Ebneth A; Verfaillie CM
    Alzheimers Dement; 2018 Oct; 14(10):1261-1280. PubMed ID: 30036493
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High-content image-based analysis and proteomic profiling identifies Tau phosphorylation inhibitors in a human iPSC-derived glutamatergic neuronal model of tauopathy.
    Cheng C; Reis SA; Adams ET; Fass DM; Angus SP; Stuhlmiller TJ; Richardson J; Olafson H; Wang ET; Patnaik D; Beauchamp RL; Feldman DA; Silva MC; Sur M; Johnson GL; Ramesh V; Miller BL; Temple S; Kosik KS; Dickerson BC; Haggarty SJ
    Sci Rep; 2021 Aug; 11(1):17029. PubMed ID: 34426604
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Brain perfusion patterns in familial frontotemporal lobar degeneration.
    Seelaar H; Papma JM; Garraux G; de Koning I; Reijs AE; Valkema R; Rozemuller AJ; Salmon E; van Swieten JC
    Neurology; 2011 Jul; 77(4):384-92. PubMed ID: 21753175
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MMP-9 and MMP-2 Contribute to Neuronal Cell Death in iPSC Models of Frontotemporal Dementia with MAPT Mutations.
    Biswas MHU; Almeida S; Lopez-Gonzalez R; Mao W; Zhang Z; Karydas A; Geschwind MD; Biernat J; Mandelkow EM; Futai K; Miller BL; Gao FB
    Stem Cell Reports; 2016 Sep; 7(3):316-324. PubMed ID: 27594586
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Frontotemporal Lobar Degeneration.
    Premi E; Padovani A; Borroni B
    Adv Exp Med Biol; 2012; 724():114-27. PubMed ID: 22411238
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic correction of tauopathy phenotypes in neurons derived from human induced pluripotent stem cells.
    Fong H; Wang C; Knoferle J; Walker D; Balestra ME; Tong LM; Leung L; Ring KL; Seeley WW; Karydas A; Kshirsagar MA; Boxer AL; Kosik KS; Miller BL; Huang Y
    Stem Cell Reports; 2013; 1(3):226-34. PubMed ID: 24319659
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human iPSC-Derived Neuronal Model of Tau-A152T Frontotemporal Dementia Reveals Tau-Mediated Mechanisms of Neuronal Vulnerability.
    Silva MC; Cheng C; Mair W; Almeida S; Fong H; Biswas MHU; Zhang Z; Huang Y; Temple S; Coppola G; Geschwind DH; Karydas A; Miller BL; Kosik KS; Gao FB; Steen JA; Haggarty SJ
    Stem Cell Reports; 2016 Sep; 7(3):325-340. PubMed ID: 27594585
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Elevated 4R-tau in astrocytes from asymptomatic carriers of the MAPT 10+16 intronic mutation.
    Setó-Salvia N; Esteras N; de Silva R; de Pablo-Fernandez E; Arber C; Toomey CE; Polke JM; Morris HR; Rohrer JD; Abramov AY; Patani R; Wray S; Warner TT
    J Cell Mol Med; 2022 Feb; 26(4):1327-1331. PubMed ID: 34951131
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sporadic four-repeat tauopathy with frontotemporal lobar degeneration, Parkinsonism, and motor neuron disease: a distinct clinicopathological and biochemical disease entity.
    Fu YJ; Nishihira Y; Kuroda S; Toyoshima Y; Ishihara T; Shinozaki M; Miyashita A; Piao YS; Tan CF; Tani T; Koike R; Iwanaga K; Tsujihata M; Onodera O; Kuwano R; Nishizawa M; Kakita A; Ikeuchi T; Takahashi H
    Acta Neuropathol; 2010 Jul; 120(1):21-32. PubMed ID: 20140439
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tau physiology and pathomechanisms in frontotemporal lobar degeneration.
    Bodea LG; Eckert A; Ittner LM; Piguet O; Götz J
    J Neurochem; 2016 Aug; 138 Suppl 1(Suppl Suppl 1):71-94. PubMed ID: 27306859
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.